KLK3 and prostate carcinoma: Currently, the screening and diagnosis of prostate cancer mainly include serum Prostate-specific Antigen (PSA), Magnetic Resonance Imaging fusion ultrasound-guided prostate biopsy (MRI-TRUS), and digital rectal examination.